statistiche ricercatore

Continente	#
NA - Nord America	1.194
EU - Europa	473
AS - Asia	172
OC - Oceania	10
SA - Sud America	8
AF - Africa	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.861

Nazione	#
US - Stati Uniti d'America	1.190
GB - Regno Unito	141
IT - Italia	74
DE - Germania	69
SE - Svezia	67
CN - Cina	45
HK - Hong Kong	35
FI - Finlandia	23
SG - Singapore	22
UA - Ucraina	22
TR - Turchia	21
BE - Belgio	13
IN - India	13
FR - Francia	12
RU - Federazione Russa	11
BG - Bulgaria	10
NL - Olanda	10
AU - Australia	9
TW - Taiwan	7
HU - Ungheria	5
KR - Corea	5
ID - Indonesia	4
IE - Irlanda	4
JP - Giappone	4
PK - Pakistan	4
VN - Vietnam	4
BR - Brasile	3
MY - Malesia	3
PT - Portogallo	3
BZ - Belize	2
CA - Canada	2
CH - Svizzera	2
CO - Colombia	2
IR - Iran	2
RO - Romania	2
TN - Tunisia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
AT - Austria	1
BH - Bahrain	1
CL - Cile	1
EC - Ecuador	1
IL - Israele	1
LT - Lituania	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PE - Perù	1
SI - Slovenia	1
TH - Thailandia	1
ZA - Sudafrica	1
Totale	1.861

Nome	#
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening	264
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women	231
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat	216
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region.	200
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors	199
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer.	198
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor	168
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study	161
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores	139
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness	119
Totale	1.895

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	376	0	0	23	31	37	90	68	42	39	17	18	11
2020/2021	328	35	12	33	35	33	16	19	35	22	47	19	22
2021/2022	273	16	14	33	16	5	22	14	22	35	22	48	26
2022/2023	307	35	40	20	38	31	33	8	36	36	1	17	12
2023/2024	193	7	12	16	14	44	13	21	30	7	4	8	17
2024/2025	28	18	4	6	0	0	0	0	0	0	0	0	0
Totale													1.895